江苏万年长药业有限公司

Jiangsu Wannianchang Pharmaceutical Co., Ltd. was established in December 2006 and is located in the beautiful coastal city of Rudong, Jiangsu. In 2015, it fully acquired Jiangsu Runju Agrochemical Co., Ltd., with a total land area of 200 acres and a workforce of 430 employees.

Jiangsu Wannianchang Pharmaceutical Co., Ltd. was established in December 2005 with a registered capital of 38.461539 million yuan. It is situated in the Yangkou Chemical Industrial Park in Rudong County, Jiangsu Province, covering an area of approximately 105 acres. The company is a privately-owned technology enterprise specializing in the research, production, and sales of pharmaceutical intermediates. It has been recognized as a Jiangsu Provincial High-Tech Enterprise and a Jiangsu Provincial Contract-Honoring and Creditworthy Enterprise. The company has established provincial-level engineering technology research centers and Nantong Municipal Enterprise Technology Centers as scientific research platforms.
The company's product lines include the Aliskiren Intermediate Series, Atorvastatin Series, Ezetimibe Series, Rosuvastatin Series, and Indole Series. It maintains a comprehensive ISO9001 quality management system.
The Ezetimibe Series product, (S)-(+)-4-phenyl-2-oxazolidinone, has passed on-site quality audits by companies such as Merck (USA) and TEVA (India).
The Aliskiren Intermediate Series product, (S)-4-Benzyl-2-oxazolidinone, has passed the on-site quality audit by Novartis (Switzerland) and serves as Novartis's production base in Asia.
The Atorvastatin Series products have passed on-site quality audits by internationally renowned companies such as Dr. Reddy's (India) and SUN, making the company a high-quality supplier for several well-known multinational corporations.
The company places great emphasis on independent intellectual property rights and currently holds over 30 intellectual property patents. It has registered six trademarks, among which the "Woside" trademark was recognized as the "2013 Nantong Famous Trademark." Six of the company's products have been designated as Jiangsu Provincial High-Tech Products, and three have been recognized as Nantong Famous Brand Products.
As a Nantong Municipal Safety Standardization Level II enterprise, the company highly prioritizes environmental protection, safety, and health investments and management. It adheres to the principles of social responsibility, emphasizes social benefits and obligations, upholds safety as the top priority, values people-oriented approaches, and balances social and economic benefits. The company continuously improves employee待遇, welfare, and production and living environments.
The company highly values product research and development and technological innovation. It has established a two-story R&D center covering approximately 1,000 square meters, with an annual R&D investment of about 10 million yuan. It has founded a Jiangsu Provincial Engineering Technology Research Center and collaborated with Soochow University to establish a provincial-level graduate workstation. The company also engages in industry-university-research partnerships with prestigious institutions such as the Shanghai Institute of Organic Chemistry (Chinese Academy of Sciences), East China University of Science and Technology, Soochow University, and Lanzhou University. In the coming years, the company will continue to increase investment in product technology R&D, strengthen collaborations with domestic and international universities, enhance its position in the domestic pharmaceutical intermediate industry, improve its technological innovation capabilities, and strengthen its market competitiveness.